Skip to main content
SpringerLink
Log in

Antioxidants and Endothelial Function: Human Studies

  • Chapter
Antioxidants and Cardiovascular Disease

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 258))

  • 954 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1–27.

    PubMed  CAS  Google Scholar 

  2. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–5.

    PubMed  CAS  Google Scholar 

  3. Joannides R, Haefeli WE, Linder L et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314–9.

    PubMed  CAS  Google Scholar 

  4. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659–64.

    PubMed  CAS  Google Scholar 

  5. Binggeli C, Spieker LE, Corti R et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 2003;42:71–7.

    PubMed  CAS  Google Scholar 

  6. Stroes E, Kastelein J, Cosentino F et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997;99:41–6.

    PubMed  CAS  Google Scholar 

  7. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997;96:25–8.

    PubMed  CAS  Google Scholar 

  8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141–8.

    PubMed  CAS  Google Scholar 

  9. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 1999;85:23–8.

    PubMed  CAS  Google Scholar 

  10. Sawamura T, Kume N, Aoyama T et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73–7.

    PubMed  CAS  Google Scholar 

  11. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 2002;39:1429–35.

    PubMed  CAS  Google Scholar 

  12. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989;64:900–14.

    PubMed  CAS  Google Scholar 

  13. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191–7.

    PubMed  CAS  Google Scholar 

  14. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333–7.

    PubMed  CAS  Google Scholar 

  15. Weinstein DB, Carew TE, Steinberg D. Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis. Biochim Biophys Acta 1976;424:404–21.

    PubMed  CAS  Google Scholar 

  16. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983;3:149–59.

    PubMed  CAS  Google Scholar 

  17. Henriksen T, Mahoney EM, Steinberg D. Interactions of plasma lipoproteins with endothelial cells. Ann N Y Acad Sci 1982;401:102–16.

    PubMed  CAS  Google Scholar 

  18. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1981;78:6499–503.

    PubMed  CAS  Google Scholar 

  19. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 1984;81:3883–7.

    PubMed  CAS  Google Scholar 

  20. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357–64.

    PubMed  CAS  Google Scholar 

  21. Berliner JA, Navab M, Fogelman AM et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488–96.

    PubMed  CAS  Google Scholar 

  22. Rajavashisth TB, Andalibi A, Territo MC et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 1990;344:254–7.

    PubMed  CAS  Google Scholar 

  23. Cushing SD, Berliner JA, Valente AJ et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990;87:5134–8.

    PubMed  CAS  Google Scholar 

  24. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086–95.

    PubMed  CAS  Google Scholar 

  25. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215–8.

    PubMed  CAS  Google Scholar 

  26. Palinski W, Rosenfeld ME, Yla-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372–6.

    PubMed  CAS  Google Scholar 

  27. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990;10:336–49.

    PubMed  CAS  Google Scholar 

  28. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A 1987;84:7725–9.

    PubMed  CAS  Google Scholar 

  29. Kita T, Nagano Y, Yokode M et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 1987;84:5928–31.

    PubMed  CAS  Google Scholar 

  30. Daugherty A, Zweifel BS, Schonfeld G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Br J Pharmacol 1991;103:1013–8.

    PubMed  CAS  Google Scholar 

  31. Mao SJ, Yates MT, Rechtin AE, Jackson RL, Van Sickle WA. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem 1991;34:298–302.

    PubMed  CAS  Google Scholar 

  32. Fruebis J, Steinberg D, Dresel HA, Carew TE. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest 1994;94:392–8.

    PubMed  CAS  Google Scholar 

  33. Morel DW, de la Llera-Moya M, Friday KE. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J Nutr 1994;124:2123–30.

    PubMed  CAS  Google Scholar 

  34. Stein Y, Stein O, Delplanque B, Fesmire JD, Lee DM, Alaupovic P. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis 1989;75:145–55.

    PubMed  CAS  Google Scholar 

  35. Daugherty A, Zweifel BS, Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br J Pharmacol 1989;98:612–8.

    PubMed  CAS  Google Scholar 

  36. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993;125:958–73.

    PubMed  CAS  Google Scholar 

  37. Kleinveld HA, Hak-Lemmers HL, Hectors MP, de Fouw NJ, Demacker PN, Stalenhoef AF. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:290–7.

    PubMed  CAS  Google Scholar 

  38. Fruebis J, Carew TE, Palinski W. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 1995; 117:217–24.

    PubMed  CAS  Google Scholar 

  39. Parker RA, Sabrah T, Cap M, Gill BT. Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb Vasc Biol 1995; 15:349–58.

    PubMed  CAS  Google Scholar 

  40. Verlangieri AJ, Bush MJ. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992; 11:131–8.

    PubMed  CAS  Google Scholar 

  41. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781–6.

    PubMed  CAS  Google Scholar 

  42. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029–35.

    Google Scholar 

  43. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145–9.

    PubMed  CAS  Google Scholar 

  44. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5.

    PubMed  CAS  Google Scholar 

  45. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;34:154–60.

    Google Scholar 

  46. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23–33.

    Google Scholar 

  47. Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668–75.

    PubMed  CAS  Google Scholar 

  48. Luscher TF, Noll G. Endothelial function as an end-point in interventional trials: concepts, methods and current data. J Hypertens Suppl 1996;14:S119–21.

    Google Scholar 

  49. Kinlay S, Behrendt D, Fang JC et al. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 2004;43:629–34.

    PubMed  CAS  Google Scholar 

  50. Gokce N, Keaney JF, Jr., Frei B et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999;99:3234–40.

    PubMed  CAS  Google Scholar 

  51. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673–8.

    PubMed  CAS  Google Scholar 

  52. Perticone F, Ceravolo R, Pujia A et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104:191–6.

    PubMed  CAS  Google Scholar 

  53. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899–906.

    PubMed  CAS  Google Scholar 

  54. Creager MA, Cooke JP, Mendelsohn ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228–34.

    PubMed  CAS  Google Scholar 

  55. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO, 3rd. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35–41.

    PubMed  CAS  Google Scholar 

  56. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO, 3rd, Quyyumi AA, Panza JA. Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol 1995;76:1157–61.

    PubMed  CAS  Google Scholar 

  57. Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491–7.

    PubMed  CAS  Google Scholar 

  58. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546–50.

    PubMed  CAS  Google Scholar 

  59. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987;84:2995–8.

    PubMed  CAS  Google Scholar 

  60. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A 1990;87:904–8.

    PubMed  CAS  Google Scholar 

  61. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76–82.

    PubMed  CAS  Google Scholar 

  62. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr 1998;133:35–40.

    PubMed  CAS  Google Scholar 

  63. Engler MM, Engler MB, Malloy MJ et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003; 108:1059–63.

    PubMed  CAS  Google Scholar 

  64. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997;95:2617–22.

    PubMed  CAS  Google Scholar 

  65. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 2002;87:264–9.

    PubMed  CAS  Google Scholar 

  66. Heitzer T, Yla Herttuala S, Wild E, Luoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 1999;33:499–505.

    PubMed  CAS  Google Scholar 

  67. Kugiyama K, Motoyama T, Doi H et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels. J Am Coll Cardiol 1999;33:1512–8.

    PubMed  CAS  Google Scholar 

  68. O’Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126–31.

    PubMed  CAS  Google Scholar 

  69. Stroes E, de Bruin T, de Valk H et al. NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc Res 1997;36:445–52.

    Google Scholar 

  70. Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 1998;32:711–6.

    PubMed  CAS  Google Scholar 

  71. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488–93.

    PubMed  CAS  Google Scholar 

  72. Beckman JA, Liao JK, Hurley S et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res 2004;95:217–23.

    PubMed  CAS  Google Scholar 

  73. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129–35.

    PubMed  CAS  Google Scholar 

  74. Yilmaz MI, Baykal Y, Kilic M et al. Effects of statins on oxidative stress. Biol Trace Elem Res 2004;98:119–27.

    PubMed  CAS  Google Scholar 

  75. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149–55.

    PubMed  CAS  Google Scholar 

  76. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6–9.

    PubMed  CAS  Google Scholar 

  77. McVeigh GE, Lemay L, Morgan D, Cohn JN. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996;78:668–72.

    PubMed  CAS  Google Scholar 

  78. Heitzer T, Yla Herttuala S, Luoma J et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996;93:1346–53.

    PubMed  CAS  Google Scholar 

  79. Motoyama T, Kawano H, Kugiyama K et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997;273:H1644–50.

    PubMed  CAS  Google Scholar 

  80. Papamichael C, Karatzis E, Karatzi K et al. Red wine’s antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am Heart J 2004;147:E5.

    PubMed  Google Scholar 

  81. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094–100.

    PubMed  CAS  Google Scholar 

  82. Heitzer T, Brockhoff C, Mayer B et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 2000;86:E36–41.

    PubMed  CAS  Google Scholar 

  83. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Stocker R, Celermajer DS. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 2000;35:1616–21.

    PubMed  CAS  Google Scholar 

  84. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997;349:837–42.

    PubMed  CAS  Google Scholar 

  85. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999;31:51–60.

    Google Scholar 

  86. Boulanger CM. Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol 1999;31:39–49.

    PubMed  CAS  Google Scholar 

  87. Noll G, Tschudi M, Nava E, Luscher TF. Endothelium and high blood pressure. Int J Microcirc Clin Exp 1997;17:273–9.

    Article  PubMed  CAS  Google Scholar 

  88. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997;20(Suppl 2):II-26–33.

    Google Scholar 

  89. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929–33.

    PubMed  CAS  Google Scholar 

  90. Taddei S, Virdis A, Mattei P et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997;29:736–43.

    PubMed  CAS  Google Scholar 

  91. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO, 3rd. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 1997;95:104–10.

    PubMed  CAS  Google Scholar 

  92. Mimran A, Ribstein J, DuCailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995;26:937–41.

    PubMed  CAS  Google Scholar 

  93. Tschudi MR, Mesaros S, Luscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 1996;27:32–5.

    PubMed  CAS  Google Scholar 

  94. Munzel T, Heitzer T, Harrison DG. The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 1997;22:158–72.

    Article  PubMed  CAS  Google Scholar 

  95. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997;96:1513–9.

    PubMed  CAS  Google Scholar 

  96. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Jr., Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107–13.

    PubMed  CAS  Google Scholar 

  97. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222–9.

    PubMed  CAS  Google Scholar 

  98. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO, 3rd, Quyyumi AA, Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension 1995;26:863–8.

    PubMed  CAS  Google Scholar 

  99. Cardillo C, Kilcoyne CM, Cannon RO, 3rd, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997;30:57–63.

    PubMed  CAS  Google Scholar 

  100. Bellamy MF, McDowell IF, Ramsey MW et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998;98:1848–52.

    PubMed  CAS  Google Scholar 

  101. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119–21.

    PubMed  CAS  Google Scholar 

  102. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999;99:1156–60.

    PubMed  CAS  Google Scholar 

  103. Nappo F, De Rosa N, Marfella R et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999;281:2113–8.

    PubMed  CAS  Google Scholar 

  104. Virdis A, Ghiadoni L, Cardinal H et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 2001;38:1106–15.

    PubMed  CAS  Google Scholar 

  105. Woodman RJ, Celermajer DE, Thompson PL, Hung J. Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects. Clin Sci (Lond) 2004;106:353–8.

    PubMed  CAS  Google Scholar 

  106. Woo KS, Chook P, Chan LL et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002;l12:535–9.

    Google Scholar 

  107. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510–6.

    PubMed  CAS  Google Scholar 

  108. McVeigh GE, Brennan GM, Johnston GD et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771–6.

    PubMed  CAS  Google Scholar 

  109. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567–74.

    PubMed  CAS  Google Scholar 

  110. Williams SB, Goldfine AB, Timimi FK et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695–701.

    PubMed  CAS  Google Scholar 

  111. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22–8.

    Article  PubMed  CAS  Google Scholar 

  112. Corretti MC, Plotnick GD, Vogel RA. The effects of age and gender on brachial artery endothelium-dependent vasoactivity are stimulus-dependent. Clin Cardiol 1995;18:471–6.

    Article  PubMed  CAS  Google Scholar 

  113. Taddei S, Virdis A, Mattei P et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995;91:1981–7.

    PubMed  CAS  Google Scholar 

  114. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468–74.

    Article  PubMed  CAS  Google Scholar 

  115. van der Loo B, Labugger R, Skepper JN et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000; 192:1731–44.

    PubMed  Google Scholar 

  116. Simons LA, von Konigsmark M, Simons J, Stacker R, Celermajer DS. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 1999; 143:193–9.

    PubMed  CAS  Google Scholar 

  117. Singh N, Graves J, Taylor PD, MacAllister RJ, Singer DR. Effects of a ‘healthy’ diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 2002;56:118–25.

    PubMed  CAS  Google Scholar 

  118. Taddei S, Galetta F, Virdis A et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000;101:2896–901.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospital and Cardiovascular Research, Institute of Physiology, University of Zürich, Switzerland

    Christian Bingelli, Isabella Sudano, Bernd van der Loo, Francesco Cosentino, Georg Noll & Thomas F. Lüscher

Authors
  1. Christian Bingelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabella Sudano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernd van der Loo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Cosentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Georg Noll
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thomas F. Lüscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Montreal Heart Institute Research Center and Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

    Martial G. Bourassa  & Jean-Claude Tardif  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Bingelli, C., Sudano, I., van der Loo, B., Cosentino, F., Noll, G., Lüscher, T.F. (2006). Antioxidants and Endothelial Function: Human Studies. In: Bourassa, M.G., Tardif, JC. (eds) Antioxidants and Cardiovascular Disease. Developments in Cardiovascular Medicine, vol 258. Springer, Boston, MA. https://doi.org/10.1007/0-387-29553-4_11

Download citation

  • DOI: https://doi.org/10.1007/0-387-29553-4_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-29552-7

  • Online ISBN: 978-0-387-29553-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation